BSXBoston Scientific

Compare with peers → Embed

Filings with the SEC since Sep 14, 2020

1,005 filings, 5 in the last 30 days

SEC filing index

Latest annual reportOpen ↗

Feb 17, 2026

10-K, period to Dec 31, 2025

Latest quarterly reportOpen ↗

Nov 2, 2026

10-Q, period to Sep 30, 2026

Latest current reportOpen ↗

Oct 28, 2026

8-K: Quarterly results

Filed in the last 30 days

of 1,005 in all

Timeline

Every filing on one line

1 yr 2 yr 3 yr

Annual report (10-K)Quarterly report (10-Q)Current report (8-K)Auditor changeCEO, CFO, COO or CAO changeRestatementLate filing noticeInsider purchaseCluster buy (3+ insiders)SEC comment letterShare offering (S-3, 424B)

20252026

All 51 events

Nov 2, 202610-Q Quarterly report (10-Q) period ended Sep 30, 2026
Oct 28, 20268-K Quarterly results 8-K item 2.02
Oct 7, 2026Officer COO and CAO change On October 7, 2026, Boston Scientific Corporation (the “Company”) announced that Joe Fitzgerald, who currently serves as Executive Vice President and Group President, Cardiovascular, has been promoted to Executive Vice President and Chief Operating Officer of the Company, effective as of January 1, 2027.
Sep 23, 20268-K Director or officer change 8-K item 5.02
Sep 8, 20268-K Cybersecurity incident 8-K item 1.05
Aug 26, 2026Buy Morano Susan E (Director) bought $100K open-market purchase on Aug 25, 2026
Aug 26, 2026Cluster buy Cluster buy: 4 insiders bought $9.5M 2026-07-31 to 2026-08-25: Mahoney Michael F, LUDWIG EDWARD J, Habiger David C, Morano Susan E
Aug 26, 20268-K Other events 8-K item 8.01
Aug 7, 2026Buy Habiger David C (Director) bought $100K open-market purchase on Aug 5, 2026
Aug 5, 2026Buy Mahoney Michael F (Chairman, President & CEO) bought $9.0M open-market purchase on Aug 3, 2026
Aug 5, 2026Buy Habiger David C (Director) bought $57K open-market purchase on Aug 3, 2026
Aug 3, 2026Buy LUDWIG EDWARD J (Director) bought $227K open-market purchase on Jul 31, 2026
Aug 3, 202610-Q Quarterly report (10-Q) period ended Jun 30, 2026
Jul 29, 20268-K Quarterly results 8-K item 2.02
Jul 27, 20268-K Restructuring or exit costs 8-K item 2.05
May 21, 2026Buy Habiger David C (Director) bought $251K open-market purchase on May 19, 2026
May 21, 2026Buy LUDWIG EDWARD J (Director) bought $203K open-market purchase on May 20, 2026
May 21, 2026Buy Pegus Cheryl (Director) bought $100K open-market purchase on May 20, 2026
May 21, 2026Cluster buy Cluster buy: 3 insiders bought $554K 2026-05-19 to 2026-05-20: Habiger David C, LUDWIG EDWARD J, Pegus Cheryl
May 18, 20268-K Other events 8-K item 8.01
May 18, 20268-K Other events 8-K item 8.01
May 5, 20268-K Bylaws or fiscal year changed, Shareholder vote results 8-K items 5.03, 5.07
May 1, 202610-Q Quarterly report (10-Q) period ended Mar 31, 2026
Apr 22, 20268-K Quarterly results 8-K item 2.02
Mar 30, 20268-K Other events 8-K item 8.01
Feb 26, 20268-K Material agreement signed, Material agreement ended, New debt or obligation 8-K items 1.01, 1.02, 2.03
Feb 23, 20268-K Director or officer change, Regulation FD disclosure, Other events 8-K items 5.02, 7.01, 8.01
Feb 17, 202610-K Annual report (10-K) period ended Dec 31, 2025
Feb 5, 20268-K Director or officer change 8-K item 5.02
Feb 4, 20268-K Quarterly results 8-K item 2.02
Jan 15, 20268-K Regulation FD disclosure 8-K item 7.01
Jan 15, 20268-K Material agreement signed 8-K item 1.01
Nov 19, 20258-K Director or officer change 8-K item 5.02
Nov 3, 202510-Q Quarterly report (10-Q) period ended Sep 30, 2025
Oct 23, 20258-K Director or officer change 8-K item 5.02
Oct 22, 20258-K Quarterly results 8-K item 2.02
Sep 4, 20258-K Director or officer change 8-K item 5.02
Aug 1, 202510-Q Quarterly report (10-Q) period ended Jun 30, 2025
Jul 23, 20258-K Quarterly results 8-K item 2.02
May 28, 20258-K Other events 8-K item 8.01
May 6, 20258-K Shareholder vote results 8-K item 5.07
May 1, 202510-Q Quarterly report (10-Q) period ended Mar 31, 2025
Apr 23, 20258-K Quarterly results 8-K item 2.02
Apr 23, 20258-K Director or officer change, Other events 8-K items 5.02, 8.01
Feb 26, 20258-K Material agreement signed, New debt or obligation, Other events 8-K items 1.01, 2.03, 8.01
Feb 18, 202510-K Annual report (10-K) period ended Dec 31, 2024
Feb 12, 20258-K Director or officer change 8-K item 5.02
Feb 5, 20258-K Quarterly results 8-K item 2.02
Jan 16, 20258-K Other events 8-K item 8.01
Nov 22, 20248-K Director or officer change 8-K item 5.02
Nov 15, 20248-K Other events 8-K item 8.01

From the SEC filing index. Insider purchases go back 180 days (the Form 4s downloaded).

Every filing

Newest first, by kind

Each form links to sec.gov

All 1005 Annual & quarterly 26 Current reports (8-K) 92 Insiders 795 Proxy & votes 15 Big owners (13D/13G) 31 Shares & debt offered 15 SEC letters 2 Other 29

Filed	Form	What it is	Period
Mar 18, 2026	DEFA14A	Extra proxy material		all files
Mar 18, 2026	DEF 14A	Proxy statement	Mar 18, 2026	all files
Mar 6, 2026	PRE 14A		Mar 6, 2026	all files
Mar 19, 2025	DEFA14A	Extra proxy material		all files
Mar 19, 2025	DEF 14A	Proxy statement	Mar 19, 2025	all files
Apr 29, 2024	DEFA14A	Extra proxy material		all files
Mar 20, 2024	DEFA14A	Extra proxy material		all files
Mar 20, 2024	DEF 14A	Proxy statement	Mar 20, 2024	all files
Mar 8, 2024	PRE 14A		Mar 7, 2024	all files
Mar 22, 2023	DEFA14A	Extra proxy material		all files
Mar 22, 2023	DEF 14A	Proxy statement	May 4, 2023	all files
Mar 23, 2022	DEFA14A	Extra proxy material		all files
Mar 23, 2022	DEF 14A	Proxy statement	May 5, 2022	all files
Mar 24, 2021	DEFA14A	Extra proxy material		all files
Mar 24, 2021	DEF 14A	Proxy statement	May 6, 2021	all files

Press releases with quarterly results are attached to the 8-Ks marked "Quarterly results"; read them on Earnings releases.

Next Earnings releases →